Breaking News

FDA advisers vote in favor of OTC birth control pill; 

May 10, 2023
JIM WATSON/AFP via Getty Images

FDA panel votes in favor of the first over-the-counter birth control pill

The panel's recommendation holds the potential to transform the way contraception is practiced in the United States.

By Ed Silverman


STAT+ | FDA reviewers had string of concerns about Sarepta's gene therapy for Duchenne, documents show

FDA staff believe Sarepta's clinical studies "conducted to date do not provide unambiguous evidence" on the therapy, the documents show.

By Jason Mast and Adam Feuerstein


STAT+ | In small study, weight loss drug boosts immune cells that help fight cancer

A small new study suggests the benefits of drugs like Wegovy and Ozempic may go beyond just cutting weight.

By Elaine Chen



Shaury Nash/Flickr

Human 'pangenome' published, with goal of making genomics more useful for diverse populations

Lack of diversity in the current reference genome undermines the promise that personalized medicine would improve the health of everyone.

By Megan Molteni


STAT+ | Google is training its generative AI to analyze medical images — and talk to doctors about them

Google has unveiled a new effort to explore generative AI's ability to become a more dynamic tool in health care.

By Casey Ross


Opinion: Three misconceptions about the accelerated drug approval pathway

Major misconceptions about the accelerated approval pathway are harming the proper regulation of rare disease treatments.

By Emil D. Kakkis and Camille Bedrosian


JOSH EDELSON/AFP via Getty Images

Opinion: The tragedy of the Golden Gate Bridge's $400 million anti-suicide net

The $400 million net proves we're approaching mental health care in this country from the wrong end of the problem.

By Sherrie Page Guyer


Opinion: Listen: The coercion built into medical privacy consent forms

In this episode of the "First Opinion Podcast," Alex Rosenblat talks about her hunt to track down a consent form she knew she never signed.

By Torie Bosch


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments